• / Free eNewsletters & Magazine
  • / My Account
Home>Search Results

Related Content

  1. Videos
  2. Articles
  1. Why J&J Bought a Big Piece of Elan

    Morningstar's Damien Conover and Alex Morozov discuss what J&J's stake in biotech Elan means for both companies.

  2. What Makes a Dividend Stock Tick

    Morningstar's Josh Peters on considering yield and growth when looking for dividend-stock opportunities.

  3. Cost-Cutting Boosting Pharma Earnings

    Big pharmaceutical companies are getting lean in an attempt to boost profitability before they lose patent protection on several important drugs, says Morningstar's Damien Conover.

  4. Upside Attraction to J&J

    Morningstar's Damien Conover discusses the prospects for J&J's stent and drug pipelines.

  1. Corporate Models For Corporate Governance: Johnson & Johnson Trust

     

  2. Oakmark Equity and Income Fund Letter to Shareholders

     

  3. Oakmark Equity and Income Fund Letter to Shareholders

     

  4. A Taxpayer’s Guide to 2013

     

Multiple Pages
ShareEmail
Print
Text Size
Comment
blog comments powered by Disqus
Our Products
Tools
Resources
Services
Upcoming Events
Conferences
Webinars

©2012 Morningstar Advisor. All right reserved.